Scientist, physician, educator, innovator, C-suite executive, and entrepreneur, with over 20 years of leadership and experience in innovating and leading teams to help solve complex and noteworthy problems in cancer, gene therapy, and immunotherapy. A board-certified physician skilled in taking direct care of and leading colleagues to manage the complex medical needs of medically fragile patients. CEO for a public company that established an international footprint, fundraising in capital markets, built executive teams and boards, and undertook multi-center cutting-edge trials. Led a large laboratory developing and implementing cellular therapies under INDs. Multiple academic appointments including Pediatrics, Oncology, and Immunology, Chief Bone Marrow Transplantation, and most recently a tenured professor at the University of Texas MD Anderson Cancer Center. Director and Leader of Boards at Secure Transfusion Services and CellChorus. You can learn more about work here: drlaurencecooper.com.KEY HIGHLIGHTS • Pioneered and led a research program translating cell and gene therapies into immunotherapies• Nearly 100 patents and over 200 publications • Principal Investigator for over 70 federal, state, and foundational grants• Chief, pediatric bone marrow transplantation• Directed multiple clinical trials in (i) non-viral gene transfer, (ii) T cells, (iii) NK cells, (iv) chimeric antigen receptors (CARs), (v) T-cell receptors (TCRs), and (vi) cytokines• Co-Author and Editor of numerous books, including Immunotherapy in Translational Cancer ResearchSeasoned academic and business teams leaderCORE COMPETENCIES T-cell therapy | NK-cell therapy | Pediatrics | Gene Therapy | Oncology | Immunotherapy | Clinical Trial Leadership | Inspiring Speaker | C-Suite Executive | Serial Life Sciences Investor and EntrepreneurPASSIONAn avid cyclist, participating in endurance rides.